Our Services

Direct-to-Patient

One of the biggest challenges in clinical trials revolve around patient recruitment and retention. In an effort to address this challenge, many Bio Pharma companies are adopting the Home-care services/ Direct-to-Patient Models and have begun implementing this approach therefore facilitating patient enrollment and increasing patient adherence.

IMP has built a suitable supply chain platform to provide solutions for clinical trial logistics in the fundamental trend of Direct-to-Patient Models.  For this unique model, it is imperative that the investigational product’s specific requirements (i.e. such as: temperature monitoring, validated shippers, ease of use of the patient kit etc.) be supported in accordance with the required quality regulations.

Careful and early planning can eliminate the many challenges posed by the Direct-to-Patient Model. IMP CSS acquires the adequate expertise to handle the supply logistics chain and specific requirements that arise for Direct-To-Patient studies.

Our Direct-to-Patient services include:

  • kit design and packaging for patients ease of use
  • transportation to the patient home in accordance to GDP guidelines
  • adequate monitoring equipment devices
  • drug administration- provided by a qualified medical team
  • patient monitoring- provided by a qualified medical team

Direct to Patient

One of the biggest challenges in clinical trials revolve around patient recruitment and retention. In an effort to address this challenge, many Bio Pharma companies are adopting the Home-care services/ Direct-to-Patient Models and have begun implementing this approach therefore facilitating patient enrollment and increasing patient adherence.

IMP has built a suitable supply chain platform to provide solutions for clinical trial logistics in the fundamental trend of Direct-to-Patient Models.  For this unique model, it is imperative that the investigational product’s specific requirements (i.e. such as: temperature monitoring, validated shippers, ease of use of the patient kit etc.) be supported in accordance with the required quality regulations.

Careful and early planning can eliminate the many challenges posed by the Direct-to-Patient Model. IMP CSS acquires the adequate expertise to handle the supply logistics chain and specific requirements that arise for Direct-To-Patient studies.

Our Direct-to-Patient services include:

  • kit design and packaging for patients ease of use
  • transportation to the patient home in accordance to GDP guidelines
  • adequate monitoring equipment devices
  • drug administration- provided by a qualified medical team
  • patient monitoring- provided by a qualified medical team